Cargando…
Mass Spectrometry-Based Analysis of Lipid Involvement in Alzheimer’s Disease Pathology—A Review
Irregularities in lipid metabolism have been linked to numerous neurodegenerative diseases. The roles of abnormal brain, plasma, and cerebrospinal fluid (CSF) lipid levels in Alzheimer’s disease (AD) onset and progression specifically have been described to a great extent in the literature. Apparent...
Autor principal: | Kelley, Andrea R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228715/ https://www.ncbi.nlm.nih.gov/pubmed/35736443 http://dx.doi.org/10.3390/metabo12060510 |
Ejemplares similares
-
Biomarkers in Alzheimer’s Disease Analysis by Mass Spectrometry-Based Proteomics
por: Liu, Yahui, et al.
Publicado: (2014) -
Mass Spectrometry Methodology in Lipid Analysis
por: Li, Lin, et al.
Publicado: (2014) -
Involvement of Lipids in Alzheimer’s Disease Pathology and Potential Therapies
por: Chew, Hannah, et al.
Publicado: (2020) -
Isobaric mass tagging and triple quadrupole mass spectrometry to determine lipid biomarker candidates for Alzheimer's disease
por: Tokuoka, Suzumi M., et al.
Publicado: (2019) -
Assessment of pathological response to therapy using lipid mass spectrometry imaging
por: Patterson, Nathan Heath, et al.
Publicado: (2016)